|Title:||5,7,3′-trihydroxy-3,4′-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway||Authors:||Torres, Fernando
|UNESCO Clasification:||32 Ciencias médicas
|Keywords:||G(2)-M Phase Arrest
Mammalian-Cells, et al
|Issue Date:||2010||Project:||Desarrollo de Nuevos, Mas Seguros y Mas Efectivos Compuestos Antileucemicos
Evaluación de Tdf Como Potencial Fármaco Antitumoral.
|Journal:||Molecular Carcinogenesis||Abstract:||Flavonoids are polyphenolic compounds which display a vast array of biological activities and are promising anticancer agents. In this study we investigated the effect of 5,7,3′-trihydroxy-3,4′-dimethoxyflavone (THDF) on viability of nine human tumor cell lines and found that it was highly cytotoxic against leukemia cells. THDF induced G2-M phase cell-cycle arrest and apoptosis through a caspase-dependent mechanism involving cytochrome c release, processing of multiple caspases (caspase-3, -6, -7, and -9) and cleavage of poly(ADP-ribose) polymerase. Overexpression of the protective mitochondrial proteins Bcl-2 and Bcl-xL conferred partial resistance to THDF-induced apoptosis. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases (MAPKs) family and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress-activated protein kinases (JNK/SAPK) and of extracellular signal-regulated kinases (ERK) 1/2. In the present study we report that THDF-induced cell death is mediated by an intrinsic dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism independent of the generation of reactive oxygen species. The results suggest that THDF could be useful in the development of novel anticancer agents.||URI:||http://hdl.handle.net/10553/50559||ISSN:||0899-1987||DOI:||10.1002/mc.20619||Source:||Molecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 (Mayo 2010)|
|Appears in Collections:||Artículos|
checked on Sep 24, 2023
WEB OF SCIENCETM
checked on Oct 2, 2022
checked on Apr 22, 2023
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.